Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec;21(1):2559506.
doi: 10.1080/21645515.2025.2559506. Epub 2025 Sep 18.

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond

Affiliations
Review

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond

Mark R Alderson et al. Hum Vaccin Immunother. 2025 Dec.

Abstract

Wide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and introduction of an affordable multivalent conjugate vaccine that covers all disease-causing serogroups in the region. With supportive funding from the UK government's Foreign, Commonwealth & Development Office, the global public health nonprofit PATH, and the Serum Institute of India Pvt. Ltd. extended their collaboration on MenAfriVac to develop, license, and World Health Organization prequalify MenFive®, an ACWYX meningococcal conjugate vaccine. The task of developing a low-priced, strongly immunogenic, pentavalent meningococcal conjugate vaccine required multiple collaborators and complex coordination, with numerous challenges and lessons learned. Importantly, MenFive has the potential to eliminate meningococcal disease outbreaks-not only in Africa (with recent deployment of outbreak response during the 2024 and 2025 meningitis seasons) but also in other regions of the world.

Keywords: African meningitis belt; Meningococcus; conjugate vaccine; meningitis; vaccination.

PubMed Disclaimer

Conflict of interest statement

Drs. Kulkarni, Pisal, LaForce, and Dhere are or were formerly employed by SIIPL, the manufacturer of MenFive. Dr. Alderson, Ms. Regan, Mr. Martellet, and Dr. Hosken are or were employed by PATH, a collaborator on MenFive’s development. Drs. Pisal and Dhere are co-inventors on 20 patent applications emerging out of in-house MenFive research at SIIPL.

References

    1. GBD 2019 Meningitis Antimicrobial Resistance Collaborators . Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023;22(8):685–13. doi: 10.1016/S1474-4422(23)00195-3. - DOI - PMC - PubMed
    1. Mazamay S, Guégan JF, Diallo N, Bompangue D, Bokabo E, Muyembe J, Taty N, Vita TP, Broutin H.. An overview of bacterial meningitis epidemics in Africa from 1928 to 2018 with a focus on epidemics “outside-the-belt”. BMC Infect Dis. 2021;21(1):1027. doi: 10.1186/s12879-021-06724-1. - DOI - PMC - PubMed
    1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;9580(369):2196–2210. doi: 10.1016/S0140-6736(07)61016-2. - DOI - PubMed
    1. World Health Organization . Weekly epidemiological record (WER). 2022. Sep 2 [accessed 2025 Aug]. https://reliefweb.int/report/world/weekly-epidemiological-record-wer-2-s....
    1. World Health Organization . Meningitis weekly bulletin. 2024. Apr 15–21 [accessed 2024 Jul]. https://cdn.who.int/media/docs/default-source/documents/emergencies/heal....

MeSH terms

LinkOut - more resources